Abstract Library

#396 Telotristat Etiprate Produces Clinical and Biochemical Responses in Patients with Symptomatic Carcinoid Syndrome: Preliminary Results of an Ongoing Phase 2, Multicenter, Open-label, Serial-ascending, European Study

Introduction: Excess serotonin (5-HT) may cause gastrointestinal (GI) symptoms (e.g., diarrhea) in carcinoid syndrome (CS) patients. Telotristat etiprate is an oral serotonin synthesis inhibitor designed to reduce peripheral 5-HT levels and alleviate GI distress.

Conference: 9th Annual ENETSConcerence (2012)

Presenting Author:

Authors: Pavel M, Wiedenmann B, Seufferlein T, Freiman J, Law L,

Keywords: carcinoid syndrome, telotristat etiprate ,